Accueil/Actions/LSTA

LSTA

USD

Lisata Therapeutics Inc. Common Stock

$2.530-0.010 (-0.394%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.540

Haut

$2.605

Bas

$2.430

Volume

0.04M

Fondamentaux de l'Entreprise

Capitalisation Boursière

22.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.04M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.87Actuel $2.530Haut $4.2

Actualités Connexes

4 nov. 2025 · 21:00

GlobeNewswire

Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of

Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

30 oct. 2025 · 12:00

GlobeNewswire

Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025

BASKING RIDGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of